Brief: Lōkahi Therapeutics™ Advances Lt-100 Development Strategy Toward Single-Injection Administration
29/07/2026 23:13
BRIEF-Lōkahi Therapeutics™ Advances Lt-100 Development Strategy Toward Single-Injection Administration July 29 (Reuters) - GlucoTrack Inc GCTK.O:
LŌKAHI THERAPEUTICS™ ADVANCES LT-100 DEVELOPMENT STRATEGY TOWARD SINGLE-INJECTION ADMINISTRATION
LOKAHI THERAPEUTICS: ANTICIPATES CLINICAL EVALUATION OF SINGLE-INJECTION LT-100 AS EARLY AS Q4 2026
Source text: ID:nBwbKVbzla
Further company coverage: GCTK.O
((((Reuters.Briefs@thomsonreuters.com;));))